Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
3
×
boston
boston blog main
boston top stories
clinical trials
fda
life sciences
national blog main
patisiran
3
×
rna interference
3
×
akcea therapeutics
drugs
hereditary transthyretin amyloidosis
inotersen
national top stories
new york blog main
new york top stories
onpattro
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
tafamidis
vyndaqel
acute hepatic porphyrias
akin akinc
aminolevulinic acid
andrew fire
barry greene
biotech
boston university
craig mello
dan ollendorf
givosiran
john berk
john maraganore
mary o'donnell
nobel prize
paul matteis
pfizer
What
alnylam
3
×
fda
medicine
ago
drug
pharmaceuticals
rna
rnai
afternoon
alnylam’s
approval
approve
approved
awaits
biological
crossed
decades
decision
discovered
fingers
friday
gets
historic
history
indicated
interference
landmark
making
nod
ok
onpattro
patients
patisiran
quick
second
seek
specifically
speedy
time
trick
Language
Current search:
patisiran
×
alnylam
×
" alnylam pharmaceuticals "
×
" rna interference "
×
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision